174 related articles for article (PubMed ID: 24128072)
1. Effective treatment of metastatic renal cell carcinoma with topical imiquimod therapy.
Okino T; Fujioka A; Nakajima H; Tarutani M; Shuin T; Sano S
J Dtsch Dermatol Ges; 2014 Feb; 12(2):155-7. PubMed ID: 24128072
[No Abstract] [Full Text] [Related]
2. Imiquimod 5% cream for the treatment of nasal lesion of metastatic renal cell carcinoma.
Asakura M; Miura H
Dermatol Ther; 2011; 24(3):375-7. PubMed ID: 21689248
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous metastasis to face and neck as a sole manifestation of an unsuspected renal cell carcinoma.
Chauhan A; Ganguly M; Nath P; Chowdhary GS
Int J Dermatol; 2011 Jan; 50(1):81-4. PubMed ID: 21182508
[No Abstract] [Full Text] [Related]
4. Topical imiquimod to treat recurrent breast cancer.
Hengge UR; Roth S; Tannapfel A
Breast Cancer Res Treat; 2005 Nov; 94(1):93-4. PubMed ID: 16172790
[No Abstract] [Full Text] [Related]
5. High-dose interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma: still the standard.
Dutcher JP
Oncology (Williston Park); 2011 Apr; 25(5):427-8. PubMed ID: 21710841
[No Abstract] [Full Text] [Related]
6. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
Miller AK; Dusing R; Meggison A; Aires D
J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of primary cutaneous follicle centre lymphoma with topical 5% imiquimod.
Stavrakoglou A; Brown VL; Coutts I
Br J Dermatol; 2007 Sep; 157(3):620-2. PubMed ID: 17553050
[No Abstract] [Full Text] [Related]
8. Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod.
Santiago Sánchez-Mateos D; Goiriz Valdés R; Daudén Tello E
Clin Exp Dermatol; 2010 Mar; 35(2):199-200. PubMed ID: 19486047
[No Abstract] [Full Text] [Related]
9. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
10. Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation.
Kupfer-Bessaguet I; Guillet G; Misery L; Carre JL; Leroy JP; Sassolas B
J Am Acad Dermatol; 2004 Oct; 51(4):635-9. PubMed ID: 15389205
[TBL] [Abstract][Full Text] [Related]
11. Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream.
Turan A; Saricaoglu H; Baskan EB; Toker SC; Tunali S
Int J Dermatol; 2009 Feb; 48(2):214-5. PubMed ID: 19200213
[No Abstract] [Full Text] [Related]
12. Effect of sunitinib on renal cell carcinoma cutaneous metastasis.
Liu SW; Guitart JG; Kuzel TM; Gandhi M; Lacouture M
Int J Dermatol; 2009 Nov; 48(11):1269-70. PubMed ID: 20064194
[No Abstract] [Full Text] [Related]
13. Topical imiquimod therapy for cutaneous T-cell lymphoma.
Do JH; McLaughlin SS; Gaspari AA
Skinmed; 2003; 2(5):316-8. PubMed ID: 14673267
[No Abstract] [Full Text] [Related]
14. [Topical treatment of melanoma skin metastases with imiquimod].
Sigüenza M; Pizarro A; Mayor M; Vidaurrázaga C; Miralles L; González-Beato M; Casado M
Actas Dermosifiliogr; 2005 Mar; 96(2):111-5. PubMed ID: 16476347
[TBL] [Abstract][Full Text] [Related]
15. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.
Vereecken P; Monsieur E; Petein M; Heenen M
J Dermatolog Treat; 2004 Apr; 15(2):120-1. PubMed ID: 15204165
[No Abstract] [Full Text] [Related]
16. Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream.
Ferreres JR; Macaya A; Jucglà A; Muniesa C; Prats C; Peyrí J
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):877-8. PubMed ID: 16898919
[No Abstract] [Full Text] [Related]
17. Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure.
Harting M; Vujevich J; Goldberg LH
Dermatol Surg; 2007 Dec; 33(12):1516-9. PubMed ID: 18076623
[No Abstract] [Full Text] [Related]
18. Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin.
Barysch MJ; Kamarashev J; Lockwood LL; Dummer R
J Dermatol; 2011 Apr; 38(4):390-2. PubMed ID: 21544945
[No Abstract] [Full Text] [Related]
19. Complete response in a cutaneous facial metastatic nodule from renal cell carcinoma after hypofractionated radiotherapy.
Gay HA; Cavalieri R; Allison RR; Finley J; Quan WD
Dermatol Online J; 2007 Oct; 13(4):6. PubMed ID: 18319003
[TBL] [Abstract][Full Text] [Related]
20. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
